Published in J Pharm Sci on October 01, 2008
Vaginal drug delivery systems for HIV prevention. AAPS J (2009) 1.51
Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges. Proc Natl Acad Sci U S A (2013) 1.50
Development and Characterization of a Vaginal Film Containing Dapivirine, a Non- nucleoside Reverse Transcriptase Inhibitor (NNRTI), for prevention of HIV-1 sexual transmission. Drug Deliv Transl Res (2011) 1.44
Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infection. J Antimicrob Chemother (2012) 1.34
Development of topical microbicides to prevent the sexual transmission of HIV. Antiviral Res (2009) 1.30
Vaginal microbicide gel for delivery of IQP-0528, a pyrimidinedione analog with a dual mechanism of action against HIV-1. Antimicrob Agents Chemother (2011) 1.25
An intravaginal ring for the simultaneous delivery of multiple drugs. J Pharm Sci (2012) 1.17
Safe and sustained vaginal delivery of pyrimidinedione HIV-1 inhibitors from polyurethane intravaginal rings. Antimicrob Agents Chemother (2011) 1.10
Compartmental transport model of microbicide delivery by an intravaginal ring. J Pharm Sci (2010) 1.09
Non-aqueous silicone elastomer gels as a vaginal microbicide delivery system for the HIV-1 entry inhibitor maraviroc. J Control Release (2011) 1.05
Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies. Int J Womens Health (2013) 1.05
The nonnucleoside reverse transcription inhibitor MIV-160 delivered from an intravaginal ring, but not from a carrageenan gel, protects against simian/human immunodeficiency virus-RT Infection. AIDS Res Hum Retroviruses (2012) 1.04
Vaginal rings for delivery of HIV microbicides. Int J Womens Health (2012) 1.04
Engineering a segmented dual-reservoir polyurethane intravaginal ring for simultaneous prevention of HIV transmission and unwanted pregnancy. PLoS One (2014) 1.00
Multipurpose prevention technologies: biomedical tools to prevent HIV-1, HSV-2, and unintended pregnancies. Infect Dis Obstet Gynecol (2011) 1.00
Sustained release of proteins from a modified vaginal ring device. Eur J Pharm Biopharm (2010) 0.96
Topical prophylaxis for HIV prevention in women: becoming a reality. Curr HIV/AIDS Rep (2011) 0.86
Novel preclinical models of topical PrEP pharmacodynamics provide rationale for combination of drugs with complementary properties. Retrovirology (2013) 0.84
Role of Marine Natural Products in the Genesis of Antiviral Agents. Chem Rev (2015) 0.82
Pharmacokinetic evaluation of tenofovir disoproxil fumarate released from an intravaginal ring in pigtailed macaques after 6 months of continuous use. J Med Primatol (2014) 0.80
Characterization of porous, dexamethasone-releasing polyurethane coatings for glucose sensors. Acta Biomater (2014) 0.79
An Intravaginal Ring for the Simultaneous Delivery of an HIV-1 Maturation Inhibitor and Reverse-Transcriptase Inhibitor for Prophylaxis of HIV Transmission. J Pharm Sci (2015) 0.77
Modified silicone elastomer vaginal gels for sustained release of antiretroviral HIV microbicides. J Pharm Sci (2014) 0.77
Microbicides for the Treatment of Sexually Transmitted HIV Infections. J Pharm (Cairo) (2014) 0.76
Current and emerging formulation strategies for the effective transdermal delivery of HIV inhibitors. Ther Deliv (2015) 0.75
Metal Ion-Loaded Nanofibre Matrices for Calcification Inhibition in Polyurethane Implants. J Funct Biomater (2017) 0.75
Response of brain tissue to chronically implanted neural electrodes. J Neurosci Methods (2005) 5.34
Neuronal cell loss accompanies the brain tissue response to chronically implanted silicon microelectrode arrays. Exp Neurol (2005) 3.21
The brain tissue response to implanted silicon microelectrode arrays is increased when the device is tethered to the skull. J Biomed Mater Res A (2007) 1.83
Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir. Eur J Pharm Sci (2009) 1.58
Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges. Proc Natl Acad Sci U S A (2013) 1.50
Design and validation of a bioreactor for engineering vocal fold tissues under combined tensile and vibrational stresses. J Biomech (2004) 1.50
Chronic response of adult rat brain tissue to implants anchored to the skull. Biomaterials (2004) 1.37
Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infection. J Antimicrob Chemother (2012) 1.34
Quantitative analysis of the tissue response to chronically implanted microwire electrodes in rat cortex. Biomaterials (2009) 1.32
Modulation of Viscoelasticity and HIV Transport as a Function of pH in a Reversibly Crosslinked Hydrogel. Adv Funct Mater (2009) 1.28
Biocompatibility of adhesive complex coacervates modeled after the sandcastle glue of Phragmatopoma californica for craniofacial reconstruction. Biomaterials (2010) 1.27
Vaginal microbicide gel for delivery of IQP-0528, a pyrimidinedione analog with a dual mechanism of action against HIV-1. Antimicrob Agents Chemother (2011) 1.25
A comparison of the tissue response to chronically implanted Parylene-C-coated and uncoated planar silicon microelectrode arrays in rat cortex. Biomaterials (2010) 1.20
Design of a semisolid vaginal microbicide gel by relating composition to properties and performance. Pharm Res (2010) 1.19
A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis. Antimicrob Agents Chemother (2012) 1.16
Contact guidance induced organization of extracellular matrix. Biomaterials (2004) 1.13
Assessment of topical microbicides to prevent HIV-1 transmission: concepts, testing, lessons learned. Antiviral Res (2013) 1.12
Acute microelectrode array implantation into human neocortex: preliminary technique and histological considerations. Neurosurg Focus (2006) 1.11
Safe and sustained vaginal delivery of pyrimidinedione HIV-1 inhibitors from polyurethane intravaginal rings. Antimicrob Agents Chemother (2011) 1.10
Effect of filament diameter and extracellular matrix molecule precoating on neurite outgrowth and Schwann cell behavior on multifilament entubulation bridging device in vitro. J Biomed Mater Res A (2006) 1.08
Substrate curvature influences the direction of nerve outgrowth. Ann Biomed Eng (2005) 1.07
Reducing surface area while maintaining implant penetrating profile lowers the brain foreign body response to chronically implanted planar silicon microelectrode arrays. Prog Brain Res (2011) 1.06
Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties. AIDS Res Hum Retroviruses (2013) 1.04
A hot-melt extruded intravaginal ring for the sustained delivery of the antiretroviral microbicide UC781. J Pharm Sci (2011) 1.01
Cyclic strain increases fibroblast proliferation, matrix accumulation, and elastic modulus of fibroblast-seeded polyurethane constructs. J Biomech (2005) 1.01
Development of a combination microbicide gel formulation containing IQP-0528 and tenofovir for the prevention of HIV infection. J Pharm Sci (2012) 1.01
Multipurpose prevention technologies: products in development. Antiviral Res (2013) 1.00
"Set it and forget it": women's perceptions and opinions of long-acting topical vaginal gels. AIDS Behav (2014) 1.00
Characterization of microglial attachment and cytokine release on biomaterials of differing surface chemistry. Biomaterials (2008) 0.99
The effect of bioreactor induced vibrational stimulation on extracellular matrix production from human derived fibroblasts. Biomaterials (2008) 0.97
Temperature and pH sensitive hydrogels: an approach towards smart semen-triggered vaginal microbicidal vehicles. J Pharm Sci (2007) 0.97
Basic fibroblast growth factor promotes neuronal survival but not behavioral recovery in the transected and Schwann cell implanted rat thoracic spinal cord. J Neurotrauma (2004) 0.95
Directed nerve outgrowth is enhanced by engineered glial substrates. Exp Neurol (2003) 0.95
Impedance characterization of microarray recording electrodes in vitro. IEEE Trans Biomed Eng (2005) 0.93
Vaginally delivered tenofovir disoproxil fumarate provides greater protection than tenofovir against genital herpes in a murine model of efficacy and safety. Antimicrob Agents Chemother (2013) 0.92
Directional neurite outgrowth is enhanced by engineered meningeal cell-coated substrates. Tissue Eng (2005) 0.90
Inducing alignment in astrocyte tissue constructs by surface ligands patterned on biomaterials. Biomaterials (2011) 0.89
Tenofovir disoproxil fumarate intravaginal ring protects high-dose depot medroxyprogesterone acetate-treated macaques from multiple SHIV exposures. J Acquir Immune Defic Syndr (2015) 0.89
The isolation of cell derived extracellular matrix constructs using sacrificial open-cell foams. Biomaterials (2010) 0.87
Measuring macrodiffusion coefficients in microbicide hydrogels via postphotoactivation scanning. Biomacromolecules (2008) 0.87
Comparison of human fibroblast ECM-related gene expression on elastic three-dimensional substrates relative to two-dimensional films of the same material. Biomaterials (2003) 0.87
Quantitative evaluation of a hydrophilic matrix intravaginal ring for the sustained delivery of tenofovir. J Control Release (2012) 0.87
Fabrication and characterization of permeable degradable poly(DL-lactide-co-glycolide) (PLGA) hollow fiber phase inversion membranes for use as nerve tract guidance channels. Biomaterials (2006) 0.85
Multivalent benzoboroxole functionalized polymers as gp120 glycan targeted microbicide entry inhibitors. Mol Pharm (2010) 0.85
The influence of substrate curvature on neurite outgrowth is cell type dependent. Exp Neurol (2008) 0.84
Inhibition of the transport of HIV in vitro using a pH-responsive synthetic mucin-like polymer system. Biomaterials (2011) 0.84
Novel preclinical models of topical PrEP pharmacodynamics provide rationale for combination of drugs with complementary properties. Retrovirology (2013) 0.84
Activity and safety of synthetic lectins based on benzoboroxole-functionalized polymers for inhibition of HIV entry. Mol Pharm (2011) 0.84
Astrocytes specifically remove surface-adsorbed fibrinogen and locally express chondroitin sulfate proteoglycans. Acta Biomater (2013) 0.83
Engineering a degradable polyurethane intravaginal ring for sustained delivery of dapivirine. Drug Deliv Transl Res (2011) 0.83
The differential influence of colocalized and segregated dual protein signals on neurite outgrowth on surfaces. Biomaterials (2007) 0.83
The influence of sub-micron inhibitory clusters on growth cone substratum attachments and CD44 expression. Biomaterials (2008) 0.82
Enzymatic triggered release of an HIV-1 entry inhibitor from prostate specific antigen degradable microparticles. Int J Pharm (2011) 0.82
Pharmacokinetics of UC781-loaded intravaginal ring segments in rabbits: a comparison of polymer matrices. Drug Deliv Transl Res (2011) 0.81
Approaches to improve the stability of the antiviral agent UC781 in aqueous solutions. Int J Pharm (2010) 0.81
Intravaginal flux controlled pump for sustained release of macromolecules. Pharm Res (2014) 0.81
The influence of the foreign body response evoked by fibroblast transplantation on soluble factor diffusion in surrounding brain tissue. J Control Release (2007) 0.81
The assessment of adeno-associated vectors as potential intrinsic treatments for brainstem axon regeneration. J Gene Med (2012) 0.80
A cell encapsulation device for studying soluble factor release from cells transplanted in the rat brain. J Control Release (2005) 0.80
Osmotic pump tablets for delivery of antiretrovirals to the vaginal mucosa. Antiviral Res (2013) 0.79
The role of well-defined patterned substrata on the regeneration of DRG neuron pathfinding and integrin expression dynamics using chondroitin sulfate proteoglycans. Biomaterials (2012) 0.79
Chemorheology of phenylboronate-salicylhydroxamate crosslinked hydrogel networks with a sulfonated polymer backbone. Macromolecules (2008) 0.79
A phase 1 randomized placebo-controlled safety and pharmacokinetic trial of a tenofovir disoproxil fumarate vaginal ring. AIDS (2016) 0.79
Hollow fiber membrane diffusive permeability regulates encapsulated cell line biomass, proliferation, and small molecule release. Biomaterials (2002) 0.79
Composite articular cartilage engineered on a chondrocyte-seeded aliphatic polyurethane sponge. Tissue Eng (2004) 0.78
Impedance characterization of microarray recording electrodes in vitro. Conf Proc IEEE Eng Med Biol Soc (2004) 0.78
Comparison of pure and mixed populations of human fetal-derived neural progenitors transplanted into intact adult rat brain. Exp Neurol (2003) 0.78
Site-specific cross-linking of proteins through tyrosine hexahistidine tags. Bioconjug Chem (2005) 0.77
Using vocally inspired mechanical conditioning to enhance the synthesis of a cell-derived biomaterial. Ann Biomed Eng (2013) 0.77
Specific covalent immobilization of proteins through dityrosine cross-links. Langmuir (2006) 0.77
Using growth factor conditioning to modify the properties of human cell derived extracellular matrix. Biotechnol Prog (2012) 0.75
Resorption rate and biocompatibility characteristics of two polyester ventilation tubes in a guinea pig model. Otolaryngol Head Neck Surg (2004) 0.75
POLYMER-ENCAPSULATED PC12 CELLS: LONG-TERM SURVIVAL AND ASSOCIATED REDUCTION IN LESION-INDUCED ROTATIONAL BEHAVIOR. Cell Transplant (1992) 0.75